Cargando…

Nanocarriers of Fe(3)O(4) as a Novel Method for Delivery of the Antineoplastic Agent Doxorubicin Into HeLa Cells in vitro

Here we report the synthesis and in vitro characterization of a redox-sensitive, magnetically inducible nanoparticle carrier system based on the doxorubicin (DOX) drug delivery model. Each quantal nanocarrier unit consists of a magnetite Fe(3)O(4) nanoparticle core that is further encapsulated in se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Kun-kun, Lyu, Yong, Yuan, Wei-tang, Wang, Gui-xian, Stratton, Harrison, Zhang, Shui-jun, Wu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499231/ https://www.ncbi.nlm.nih.gov/pubmed/31110964 http://dx.doi.org/10.3389/fonc.2019.00250

Ejemplares similares

A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity
por: Panagiotaki, Katerina N., et al.
Publicado: (2017)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

FePt nanoparticles as a potential X-ray activated chemotherapy agent for HeLa cells
por: Zheng, Yanhong, et al.
Publicado: (2015)

Efficient uptake and retention of iron oxide-based nanoparticles in HeLa cells leads to an effective intracellular delivery of doxorubicin
por: Popescu, R. C., et al.
Publicado: (2020)

Doxorubicin Inhibits Phosphatidylserine Decarboxylase and Modifies Mitochondrial Membrane Composition in HeLa Cells
por: Bellance, Nadège, et al.
Publicado: (2020)

Intracellular Delivery of Doxorubicin by Iron Oxide-Based Nano-Constructs Increases Clonogenic Inactivation of Ionizing Radiation in HeLa Cells
por: Popescu, Roxana Cristina, et al.
Publicado: (2021)

Co-encapsulation of magnetic Fe(3)O(4) nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
por: Jia, Yanhui, et al.
Publicado: (2012)

On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents
por: Silvestris, Nicola, et al.
Publicado: (2020)

Inhibition of HeLa cell growth by doxorubicin-loaded and tuftsin-conjugated arginate-PEG microparticles
por: Hu, Tianmu, et al.
Publicado: (2017)

Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells
por: Ziganshina, Albina Y., et al.
Publicado: (2023)

Ag/AgFeO(2): An Outstanding Magnetically Responsive Photocatalyst for HeLa Cell Eradication
por: Chuah, Xui-Fang, et al.
Publicado: (2017)

Purified Vitexin Compound 1 Serves as a Promising Antineoplastic Agent in Ovarian Cancer
por: Ma, Kewen, et al.
Publicado: (2021)

Lysophosphatidic acid protects cervical cancer HeLa cells from apoptosis induced by doxorubicin hydrochloride
por: Wang, Xibo, et al.
Publicado: (2022)

Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication
por: Chen, Yu, et al.
Publicado: (2021)

Electrolyte Metabolism in HeLa Cells
por: Wickson-ginzburg, Margaret, et al.
Publicado: (1963)

Editorial: HeLa Cell Sequela
Publicado: (2013)

The fractured genome of HeLa cells
por: Mittelman, David, et al.
Publicado: (2013)

Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy
por: Katopodi, Theodora, et al.
Publicado: (2022)

Transcriptomics Reveals the Mevalonate and Cholesterol Pathways Blocking as Part of the Bacterial Cyclodipeptides Cytotoxic Effects in HeLa Cells of Human Cervix Adenocarcinoma
por: Lázaro-Mixteco, Pedro E., et al.
Publicado: (2022)

Antineoplastic activity of a novel ruthenium complex against human hepatocellular carcinoma (HepG2) and human cervical adenocarcinoma (HeLa) cells
por: Alves de Souza, Carlos Eduardo, et al.
Publicado: (2020)

Determination of the relationship between doxorubicin resistance and Wnt signaling pathway in HeLa and K562 cell lines
por: Mutlu, Pelin, et al.
Publicado: (2018)

Inhibition of Thioredoxin Reductase by Santamarine Conferring Anticancer Effect in HeLa Cells
por: Zhang, Junmin, et al.
Publicado: (2021)

Electrolyte Disorders Induced by Antineoplastic Drugs
por: Verzicco, Ignazio, et al.
Publicado: (2020)

Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier
por: Lu, Jianqin, et al.
Publicado: (2014)

Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy
por: Guo, Wei, et al.
Publicado: (2020)

Microtubule-associated proteins of HeLa cells: heat stability of the 200,000 mol wt HeLa MAPs and detection of the presence of MAP-2 in HeLa cell extracts and cycled microtubules
Publicado: (1982)

Metabolic Conversion of Ceramides in HeLa Cells - A Cholesteryl Phosphocholine Delivery Approach
por: Kjellberg, Matti A., et al.
Publicado: (2015)

Functionalized Fluorescent Nanodiamonds for Simultaneous Drug Delivery and Quantum Sensing in HeLa Cells
por: Tian, Yuchen, et al.
Publicado: (2022)

On the dynamics of the microfilament system in HeLa cells
por: Blikstad, I, et al.
Publicado: (1982)

Exploring the HeLa Dark Mitochondrial Proteome
por: Marini, Federica, et al.
Publicado: (2020)

Non-homologous End Joining Inhibitor SCR-7 to Exacerbate Low-dose Doxorubicin Cytotoxicity in HeLa Cells
por: Kumar, Ajay, et al.
Publicado: (2017)

Inhibition of Wnt-β-Catenin Signaling by ICRT14 Drug Depends of Post-Transcriptional Regulation by HOTAIR in Human Cervical Cancer HeLa Cells
por: Trujano-Camacho, Samuel, et al.
Publicado: (2021)

Anti-cancer properties of Caulerpa racemosa by altering expression of Bcl-2, BAX, cleaved caspase 3 and apoptosis in HeLa cancer cell culture
por: Permatasari, Happy Kurnia, et al.
Publicado: (2022)

A Novel Insight into the Cardiotoxicity of Antineoplastic Drug Doxorubicin
por: Heger, Zbynek, et al.
Publicado: (2013)

The Enhanced Inhibitory Effect of Different Antitumor Agents in Self-Microemulsifying Drug Delivery Systems on Human Cervical Cancer HeLa Cells
por: Ujhelyi, Zoltán, et al.
Publicado: (2015)

Fate of micronuclei and micronucleated cells after treatment of HeLa cells with different genotoxic agents
por: Reimann, Hauke, et al.
Publicado: (2022)

Correction to “Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier”
por: Lu, Jianqin, et al.
Publicado: (2019)

The use of 1H spin echo NMR and HPLC to confirm doxorubicin induced depletion of glutathione in the intact HeLa cell.
por: al-Kabban, M., et al.
Publicado: (1988)

Microfluidics delivery of DARPP-32 into HeLa cells maintains viability for in-cell NMR spectroscopy
por: Sciolino, Nicholas, et al.
Publicado: (2022)

Poly A- Transcripts Expressed in HeLa Cells
por: Wu, Qingfa, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rb30kuhk9o5bj3qecec6sijr8c